Malignant inflammation in cutaneous T-cell lymphoma: a hostile takeover

Cutaneous T-cell lymphomas (CTCL) are characterized by the presence of chronically inflamed skin lesions containing malignant T cells. Early disease presents as limited skin patches or plaques and exhibits an indolent behavior. For many patients, the disease never progresses beyond this stage, but i...

Full description

Bibliographic Details
Main Authors: Krejsgaard, Thorbjørn, Lindahl, Lise M, Mongan, Nigel P., Wasik, Mariusz A., Litvinov, Ivan V., Iversen, Lars, Langhoff, Erik, Woetmann, Anders, Odum, Niels
Format: Article
Published: Springer 2016
Subjects:
Online Access:https://eprints.nottingham.ac.uk/37454/
_version_ 1848795461520982016
author Krejsgaard, Thorbjørn
Lindahl, Lise M
Mongan, Nigel P.
Wasik, Mariusz A.
Litvinov, Ivan V.
Iversen, Lars
Langhoff, Erik
Woetmann, Anders
Odum, Niels
author_facet Krejsgaard, Thorbjørn
Lindahl, Lise M
Mongan, Nigel P.
Wasik, Mariusz A.
Litvinov, Ivan V.
Iversen, Lars
Langhoff, Erik
Woetmann, Anders
Odum, Niels
author_sort Krejsgaard, Thorbjørn
building Nottingham Research Data Repository
collection Online Access
description Cutaneous T-cell lymphomas (CTCL) are characterized by the presence of chronically inflamed skin lesions containing malignant T cells. Early disease presents as limited skin patches or plaques and exhibits an indolent behavior. For many patients, the disease never progresses beyond this stage, but in approximately one third of patients, the disease becomes progressive, and the skin lesions start to expand and evolve. Eventually, overt tumors develop and the malignant T cells may disseminate to the blood, lymph nodes, bone marrow, and visceral organs, often with a fatal outcome. The transition from early indolent to progressive and advanced disease is accompanied by a significant shift in the nature of the tumor-associated inflammation. This shift does not appear to be an epiphenomenon but rather a critical step in disease progression. Emerging evidence supports that the malignant T cells take control of the inflammatory environment, suppressing cellular immunity and anti-tumor responses while promoting a chronic inflammatory milieu that fuels their own expansion. Here, we review the inflammatory changes associated with disease progression in CTCL and point to their wider relevance in other cancer contexts. We further define the term "malignant inflammation" as a pro-tumorigenic inflammatory environment orchestrated by the tumor cells and discuss some of the mechanisms driving the development of malignant inflammation in CTCL.
first_indexed 2025-11-14T19:32:27Z
format Article
id nottingham-37454
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:32:27Z
publishDate 2016
publisher Springer
recordtype eprints
repository_type Digital Repository
spelling nottingham-374542020-05-04T18:17:42Z https://eprints.nottingham.ac.uk/37454/ Malignant inflammation in cutaneous T-cell lymphoma: a hostile takeover Krejsgaard, Thorbjørn Lindahl, Lise M Mongan, Nigel P. Wasik, Mariusz A. Litvinov, Ivan V. Iversen, Lars Langhoff, Erik Woetmann, Anders Odum, Niels Cutaneous T-cell lymphomas (CTCL) are characterized by the presence of chronically inflamed skin lesions containing malignant T cells. Early disease presents as limited skin patches or plaques and exhibits an indolent behavior. For many patients, the disease never progresses beyond this stage, but in approximately one third of patients, the disease becomes progressive, and the skin lesions start to expand and evolve. Eventually, overt tumors develop and the malignant T cells may disseminate to the blood, lymph nodes, bone marrow, and visceral organs, often with a fatal outcome. The transition from early indolent to progressive and advanced disease is accompanied by a significant shift in the nature of the tumor-associated inflammation. This shift does not appear to be an epiphenomenon but rather a critical step in disease progression. Emerging evidence supports that the malignant T cells take control of the inflammatory environment, suppressing cellular immunity and anti-tumor responses while promoting a chronic inflammatory milieu that fuels their own expansion. Here, we review the inflammatory changes associated with disease progression in CTCL and point to their wider relevance in other cancer contexts. We further define the term "malignant inflammation" as a pro-tumorigenic inflammatory environment orchestrated by the tumor cells and discuss some of the mechanisms driving the development of malignant inflammation in CTCL. Springer 2016-10-07 Article PeerReviewed Krejsgaard, Thorbjørn, Lindahl, Lise M, Mongan, Nigel P., Wasik, Mariusz A., Litvinov, Ivan V., Iversen, Lars, Langhoff, Erik, Woetmann, Anders and Odum, Niels (2016) Malignant inflammation in cutaneous T-cell lymphoma: a hostile takeover. Seminars in Immunopathology . pp. 1-14. ISSN 1863-2300 Cutaneous T-cell lymphoma Malignant T cells Inflammation Pathogenesis Cancer Infection http://link.springer.com/article/10.1007%2Fs00281-016-0594-9 doi:10.1007/s00281-016-0594-9 doi:10.1007/s00281-016-0594-9
spellingShingle Cutaneous T-cell lymphoma
Malignant T cells
Inflammation
Pathogenesis
Cancer
Infection
Krejsgaard, Thorbjørn
Lindahl, Lise M
Mongan, Nigel P.
Wasik, Mariusz A.
Litvinov, Ivan V.
Iversen, Lars
Langhoff, Erik
Woetmann, Anders
Odum, Niels
Malignant inflammation in cutaneous T-cell lymphoma: a hostile takeover
title Malignant inflammation in cutaneous T-cell lymphoma: a hostile takeover
title_full Malignant inflammation in cutaneous T-cell lymphoma: a hostile takeover
title_fullStr Malignant inflammation in cutaneous T-cell lymphoma: a hostile takeover
title_full_unstemmed Malignant inflammation in cutaneous T-cell lymphoma: a hostile takeover
title_short Malignant inflammation in cutaneous T-cell lymphoma: a hostile takeover
title_sort malignant inflammation in cutaneous t-cell lymphoma: a hostile takeover
topic Cutaneous T-cell lymphoma
Malignant T cells
Inflammation
Pathogenesis
Cancer
Infection
url https://eprints.nottingham.ac.uk/37454/
https://eprints.nottingham.ac.uk/37454/
https://eprints.nottingham.ac.uk/37454/